381 related articles for article (PubMed ID: 16091868)
21. [The PSA test does not hold for screening. Good--but not good enough].
Holmström B; Johansson M; Bratt O; Stattin P
Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
[No Abstract] [Full Text] [Related]
22. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
Richard F
Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
[No Abstract] [Full Text] [Related]
23. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.
Valicenti RK; DeSilvio M; Hanks GE; Porter A; Brereton H; Rosenthal SA; Shipley WU; Sandler HM;
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1064-71. PubMed ID: 16979837
[TBL] [Abstract][Full Text] [Related]
24. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
25. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Bratt O; Björk T
Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
[No Abstract] [Full Text] [Related]
26. Screening for prostate cancer: current recommendations.
Wilson SS; Crawford ED
Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402
[TBL] [Abstract][Full Text] [Related]
27. Weighing the benefits and downsides of prostate-specific antigen screening.
Pignone M
Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
[No Abstract] [Full Text] [Related]
28. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
Medvedev VL
Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
[No Abstract] [Full Text] [Related]
29. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
30. Solving the overdiagnosis dilemma.
Esserman L; Thompson I
J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
[No Abstract] [Full Text] [Related]
31. No one dies from prostate cancer?
Chau D
Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1526. PubMed ID: 16864764
[No Abstract] [Full Text] [Related]
32. [Screening for prostate cancer--what does the evidence show?].
Borre M; Iversen P
Ugeskr Laeger; 2007 May; 169(20):1887-8. PubMed ID: 17553362
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer and PSA screening.
Mameghan H
Aust Fam Physician; 1999 Aug; 28(8):777-81. PubMed ID: 10495525
[TBL] [Abstract][Full Text] [Related]
34. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
Kvåle R; Hernes E; Bray F
Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
[No Abstract] [Full Text] [Related]
35. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
Bastian PJ; Stief CG
MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
[No Abstract] [Full Text] [Related]
36. Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
Shariat SF; Karakiewicz PI
Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050
[No Abstract] [Full Text] [Related]
37. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
38. Is prostate cancer screening justified in the Bedouin population?
Abdallah M; Lazarev I; Ariad S; Mermershtain W
Onkologie; 2009 May; 32(5):260-2. PubMed ID: 19420972
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific antigen testing for the diagnosis of prostate cancer.
McKenzie P; Delahunt B; deVoss K; Ross B; Tran H; Sikaris K
Pathology; 2011 Aug; 43(5):403. PubMed ID: 21753713
[No Abstract] [Full Text] [Related]
40. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
Carroll PR; Whitson JM; Cooperberg MR
J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]